Cluster 4 comprised hallmark pathways associated with cell proliferation (G2M checkpoint, E2F targets, MYC targets), DNA repair and tumor suppressor loss, and the MetB signature associated with a low AR/high proliferation prostate cancer phenotype [15]. Here, MYC is linked to prostate carcinoma.